Get the Stockscreener App
0.8278
1.04%
-0.0087
After Hours:
.83
0.0022
+0.27%
iBio Inc stock is traded at $0.8278, with a volume of 179.97K.
It is down -1.04% in the last 24 hours and up +1.24% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.8365
Open:
$0.808
24h Volume:
179.97K
Relative Volume:
0.20
Market Cap:
$16.27M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1248
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+3.83%
1M Performance:
+1.24%
6M Performance:
-79.41%
1Y Performance:
-62.71%
1-Day Range:
$0.8011
$0.8364
1-Week Range:
$0.78
$0.85
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.8278 | 16.44M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
iBio Inc Stock (IBIO) Latest News
Why iBio Inc. (0JV0) stock could be next leaderAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Is iBio Inc. stock ready for a breakoutWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Using data models to predict iBio Inc. stock movementWeekly Investment Report & Expert Curated Trade Ideas - newser.com
Is iBio Inc. (0JV0) stock worth holding before Fed meetingWatch List & Stepwise Trade Signal Guides - newser.com
Can iBio Inc. stock double in next 5 yearsJuly 2025 Momentum & Weekly Market Pulse Alerts - newser.com
Real time alert setup for iBio Inc. performanceJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Is iBio Inc. (0JV0) stock a contrarian opportunity2025 Top Gainers & High Yield Stock Recommendations - newser.com
Using Ichimoku Cloud for iBio Inc. technicalsEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Detecting support and resistance levels for iBio Inc.2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Is iBio Inc 0JV0 a good long term investmentMid Cap Growth Trends & High Profit Portfolio Growth - earlytimes.in
What drives iBio Inc stock priceSector Rotation Strategies & Low Cost Wealth Strategies - earlytimes.in
Will breakout in iBio Inc. lead to full recoveryWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
iBio (IBIO) versus Its Peers Financial Analysis - Defense World
What moving averages say about iBio Inc.M&A Rumor & Technical Pattern Based Signals - newser.com
Contrasting iBio (IBIO) and The Competition - Defense World
Stock Analysis: Will iBio Inc benefit from green energy policiesJuly 2025 Breakouts & Low Drawdown Investment Strategies - خودرو بانک
Levels Update: Does KORE have a sustainable dividendVolume Spike & Advanced Swing Trade Entry Alerts - khodrobank.com
Is iBio Inc. a candidate for recovery playJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
Is iBio Inc. showing signs of accumulationEarnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Market Overview: Should I trade or invest in Lee Enterprises IncorporatedWeekly Trading Summary & Verified Technical Trade Signals - khodrobank.com
Comparing iBio Inc. in custom built stock radarsJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):